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Abstract 29 
OBJECTIVE: To determine multi-disciplinary perceptions of the clinical significance of medication 30 
errors (MEs), the responsible health professional(s), the contributing factors and potential preventive 31 
strategies. 32 
METHODS: The five simulated ME cases represented errors from five wards at a children’s hospital 33 
in Australia. Pre-determined answers for each case were developed through consensus among the 34 
researchers. The root cause analysis (RCA) was undertaken via a questionnaire disseminated to 35 
physicians, nurses and pharmacists at the study hospital to seek their opinions on the ME cases.  36 
Agreement model between the participants and pre-determined responses regarding the contributing 37 
factors was conducted using general estimating equation (GEE) analysis. 38 
RESULTS: Of the 111 RCA questionnaires distributed, 25 questionnaires were returned. The 39 
majority (93%) of respondents rated the significance of the MEs as either ‘moderate’ or ‘life-40 
threatening’. Furthermore, they correctly identified two contributing factors relevant to all cases: 41 
dismissal of policies/procedures or guidelines (90%) and human resources issues (87%). GEE 42 
analysis revealed varied agreement patterns across the contributing factors. Suggested prevention 43 
strategies focused on policy and procedures, staffing and supervision, and communication.  44 
CONCLUSION: Simulated case studies had potential use to seek front-line healthcare professionals’ 45 
understanding of the clinical significance and contributing factors to MEs, along with preventive 46 
measures. 47 
Keywords: Medication error, root cause analysis, paediatrics. 48 
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1. Introduction 57 
Health service provision occurs in a complex and high-risk environment. Errors usually suggest 58 
organisational system failure [1, 2]. Root cause analysis (RCA) is a form of system analysis that may 59 
be used to investigate incident reports, as well as a tool for academic research or training. RCA 60 
encompasses methods for retrospective, structured investigation of adverse incidents, near misses and 61 
sentinel events [3]. There is broad consensus that RCA can be completed via different approaches 62 
instead of a single method. One commonality between these approaches is the organisation of the 63 
RCA in sequential steps [4]. 64 
When applied to health systems, RCA can be used to investigate all subsets of medication 65 
misadventure, e.g. adverse drug events, adverse drug reactions and medication errors (MEs) [5]. In 66 
Australia, medication misadventure places a significant burden on the health system, accounting for 67 
2.4-3.6% of all hospital admissions in general patients, with up to 69% of these misadventures being 68 
potentially preventable [6]. In the United States of America (USA), MEs account for a significant 69 
proportion of errors during healthcare delivery [7]. In the United Kingdom, a 2007 National Patient 70 
Safety Agency report cited over 86,000 incidents relating to ME in that year [8]. 71 
Some patient groups are particularly vulnerable to ME and their consequences. Studies of ME in 72 
paediatric inpatients have reported incidence rates of 6% [9, 10] to 13% [11]. However, further 73 
research is required to identify the medications of most concern and the children at greatest risk [12, 74 
13]. 75 
Effective system improvement ascertains the underlying causes of ME through well-structured 76 
investigations utilising RCA [5]. MEs are preventable and independent of the patient’s physiology 77 
and pathology, and hence are particularly suitable for RCA to prevent recurrence. Research suggests 78 
that multiple health professionals, particularly those at the patient care interface, are commonly 79 
implicated in the occurrence of MEs [7, 14]. However, research into the contribution of frontline 80 
health professionals in preventing MEs, particularly in high-risk areas such as paediatrics, is lacking. 81 
 82 
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RCA in healthcare settings such as surgery, emergency and pharmacy has been conducted using 83 
authentic cases reviewed by medication safety teams [15-17]. Learning opportunities using this 84 
approach are limited by the confidentiality of authentic cases. Use of simulated cases in RCA has 85 
demonstrated improvements in terms of confidence and technical skills of staff, and ME reduction 86 
[18]. RCA involving simulated cases may promote awareness and understanding of medication safety 87 
issues including MEs without the fear of legal ramifications [18, 19]. 88 
This study aimed to apply RCA using a sample of simulated cases to determine multi-disciplinary 89 
perceptions of the clinical significance of MEs and the responsible health professional(s). 90 
Additionally, it aimed to investigate participants’ views on the contributing factors for the MEs and 91 
strategies to reduce error recurrence. 92 
2. Methods 93 
2.1 Development of Simulated Clinical Case Studies and the Survey Instrument 94 
The principal researcher developed five simulated cases depicting paediatric patients, as described in 95 
the Results section. The cases were based on the most common types of MEs observed in a major 96 
children’s teaching hospital in Western Australia [20]. Each case demonstrated one of the following 97 
errors: prescribing error (setting = General Medical Ward for Infants), dispensing error (General 98 
Medical Ward for Young Children), administration error (General Medical Ward for Adolescents), 99 
transcribing error (Hematology-Oncology Ward) and monitoring error (General Surgical Ward). The 100 
cases were constructed such that any nurse, physician or pharmacist could reflect on the scenario, 101 
regardless of their specialty. Each case was reviewed by two experienced academic pharmacists for 102 
accuracy of clinical information and representativeness of practice at the study hospital. For each 103 
case, four or five contributing factors were pre-determined by the academic pharmacists and principal 104 
researcher to allow comparison with the participants’ responses. Three contributing factors were 105 
common to all cases: dismissal of policies/procedures or guidelines, human resources, and 106 
miscommunication (Table 1). Content and face validity of the questionnaire were reviewed by the 107 
academic pharmacists. 108 
 109 
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The questionnaire (available on request) was designed for self-completion by health professionals, 110 
and comprised two sections. Section 1 documented participants’ demographic characteristics (age, 111 
gender, health profession, position, and years of experience as a health professional overall and in 112 
paediatrics). Section 2 presented the five cases, followed by questions related to the ME and RCA. 113 
ME-related questions required rating of the clinical significance of the error, as per methods reported 114 
by the National Coordinating Council for Medication Error Reporting and Prevention/NCCMERP 115 
[21] and identification of the health professional(s) perceived to have significantly contributed to the 116 
error. RCA questions were adapted from the Clinical Incident Management Toolkit [22], whereby 117 
participants identified the contributing factor(s) from six categories: specific patient issues, dismissal 118 
of policies/procedures/guidelines, human resources-related issues, communication-related issues, 119 
physical environment of the health service, and control/provision of medication. ‘Unsure’ and ‘other’ 120 
options were also provided. Participants were also asked to suggest strategies to prevent recurrence of 121 
the error. Questionnaires were produced in hard copy and code-numbered, only allowing 122 
identification of respondents by health professional group (accompanying consent forms were 123 
collected separately). 124 
2.2 Participants and Questionnaire Administration 125 
One hundred and eleven questionnaires were distributed during study period (July-October 2014). 126 
Potential participants included all pharmacists in the hospital (n=37) and a convenience sample (20%) 127 
of physicians (n=31; 5-6 physicians/ward) and nurses (n=43; 8-9 nurses/ward) from the five study 128 
wards, with the intention to generate comparable numbers of responses that could be compared 129 
descriptively. There is little published guidance for sampling in RCA studies; our intention was 130 
exploratory analysis to compare patterns of agreement with the predetermined answers. 131 
The principal researcher  handed the questionnaires directly to all 37 pharmacists. To introduce the 132 
study to physicians and nurses, questionnaires were distributed by the ward pharmacists or the 133 
principal researcher under supervision of a ward pharmacist, using convenience sampling, to reach the 134 
predefined number of potential participants per ward. Two reminders were emailed to all pharmacists 135 
in August and September, while prompts to physicians and nurses were provided by the ward 136 
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pharmacists via email and/or ward meetings. Participants were asked to return the questionnaires and 137 
the consent form by the predefined time in the envelope provided. The survey period was limited by 138 
upcoming hospital accreditation. 139 
2.3 Data Analysis 140 
All data were entered into SPSS version 22.0. General Estimating Equation (GEE) analysis [23] was 141 
used to develop an agreement model between the groups of participants’ responses to the contributing 142 
factors and the pre-determined answers for each case. The dependent variable in the GEE model was 143 
disagreement regarding each factor. An odds ratio greater than one indicated greater disagreement 144 
than the reference. In comparing the simulated cases, Case 5 was set as the reference. If the agreement 145 
model using GEE was not able to be fitted (e.g. due to unanimous agreement), the results were 146 
summarised using descriptive statistics. Participants’ comments regarding the contributing factors 147 
were entered into QSR NVivo version 10.0 to assist coding of emergent themes.  148 
2.4 Ethics approval 149 
Study approval was granted by the Human Research Ethics Committees of the study hospital (2923) 150 
and university (PH-14-112923).  151 
3. Results 152 
Of the 111 RCA questionnaires administered to physicians, nurses and pharmacists, six (19%), 11 153 
(26%) and eight (22%) were returned, respectively (overall response rate 23%). All of the returned 154 
questionnaires were included in the analysis. This sample size, while low, enabled the planned 155 
analysis. Most participants (52%) were aged 31 to 40 years, and the majority (84%) identified as 156 
female. Each group showed a similar pattern of clinical experience (Table 2). Three of the physicians 157 
were registrars and three were consultants/specialists. Four of the nurses were clinical nurses/clinical 158 
midwives/clinical development nurses, and one was a clinical nurse/midwife consultant. Four of the 159 
pharmacists held clinical pharmacist roles.  160 
3.1 Analysis of the Cases 161 
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Case 1 hypothetically described a prescribing error involving digoxin, a high-risk drug, in a six-162 
month-old baby. The physician wrote the digoxin dose inappropriately (not including a leading zero 163 
before the decimal point), resulting in a 100-fold higher dose and patient death. All but one of the 164 
participants rated the error as ‘life threatening’. All physicians and pharmacists perceived all three 165 
health professionals (physician, nurse, pharmacist) as accountable. Nine of the 11 nurses agreed, 166 
while the remaining two nurses pointed to their own profession as primarily responsible.  167 
Case 2 illustrated a dispensing error where a locum pharmacist with poor vision and inadequate 168 
supervision filled medication orders for a patient with a history of seizures. The dispensary was 169 
arranged alphabetically by generic name, and the locum dispensed prednisolone instead of primidone. 170 
All nurses and pharmacists rated the error as ‘major’ or ‘life threatening’. The majority of the 171 
physicians (83%) offered a similar assessment. Most (76%) participants identified two health 172 
professionals (i.e. nurse and pharmacist) as responsible. 173 
Case 3 described an error during drug administration. The patient, with a history of asthma and 174 
seizures, was admitted due to asthma exacerbation. As levetiracetam was out of stock, five doses of 175 
levetiracetam were omitted, triggering a seizure. All physicians and pharmacists and just over half 176 
(55%) of the nurses rated the error as ‘major’. There was little consensus between the groups 177 
regarding who was responsible for the error. 178 
Case 4 illustrated inadequate communication and documentation resulting in an anaphylactic reaction 179 
in a patient with history of penicillin allergy. Over half (physicians 67%, nurses 55%, pharmacists 180 
88%) assessed the error as ‘life threatening’, with varied perspectives about responsibility.  181 
Case 5 related to a transcribing error, where an antifungal medicine was not re-charted for a newly-182 
diagnosed oncology patient. A non-oncology nurse had been deployed to this ward, and was unable to 183 
identify the error. Over half of the nurses (55%) and the pharmacists (63%) rated the error as ‘major’ 184 
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in significance, whilst physicians most commonly (50%) considered it ‘moderate’. All respondents 185 
felt the physician had some responsibility for the error. 186 
All errors were considered to have multiple contributing factors (Table 3). Dismissal of hospital 187 
policies/protocols/clinical guidelines and human resources were perceived as the key issues in all 188 
cases. In addition, half of the participants indicated that patient-specific issues had contributed to the 189 
error in Case 1 (complexity of medical condition and young age) and Case 4 (patient’s drug allergy).  190 
Participants’ comments relating to contributing factors identified the following themes: 191 
miscommunication between staff, miscommunication between staff and the patient and/or patient 192 
family, poor lighting, workspace, medication storage, documentation of administration, internal 193 
transfer of medication, and staff health (only applicable to Case 2).  194 
Suggestions regarding ME prevention mapped to the following themes: improved availability and 195 
accessibility of clinical guidelines and strict adherence to hospital policies/protocols for high-risk 196 
drugs; adequate staffing and staff supervision; adequate staff education and training/competencies; 197 
effective communication between staff; patient empowerment (e.g. through education and 198 
counseling); use of technology (e.g. electronic prescribing); and improving the physical environment 199 
of the healthcare facilities (e.g. pharmacy layout). 200 
3.2 Agreement between Pre-Determined Contributing Factors and Participants’ Responses 201 
Of the six contributing factors, two demonstrated convergence in the GEE model, due to very high or 202 
complete agreement between responses from health professional groups and the pre-determined 203 
factor. These factors were dismissal of policies/procedures or guidelines, and physical environment of 204 
the health service. 205 
Table 4 outlines the agreement model for the remaining four factors using GEE analysis. The analysis 206 
showed significantly greater agreement about the contribution of patient-specific issues (i.e. low odds 207 
ratios) for Cases 2 (dispensing error) and 4 (communication and documentation error) compared to 208 
Case 5 (transcribing error). Case 4 was an outlier regarding human resources issues, with the high 209 
odds ratio suggesting disagreement that human resources issues contributed to the communication and 210 
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documentation error. The participants were more likely to agree with the contribution of 211 
communication in Case 3 (error during drug administration) and Case 4 (inadequate communication 212 
and documentation), compared to Case 5 (transcribing error). With respect to control/provision of 213 
medication as the contributing factor, the agreement with the pre-determined factors was similar 214 
across all professions. The level of agreement was significantly higher for Case 4 than for Case 5. 215 
4. Discussion 216 
This study used paper-based simulated case studies; this method can reflect reality without potentially 217 
identifying individuals implicated in authentic errors reported through hospital safety and quality 218 
systems [18, 19]. Overall, a similar perspective was revealed among the participants across the three 219 
professions on the clinical significance of the MEs, with the majority of participants rating the MEs as 220 
“major” or “life threatening”, as intended in the design of the cases. However, the present findings 221 
were not consistent with prior studies assessing medication-related events (i.e. MEs) either in 222 
paediatric or adult patients. In such studies, physicians often rated the severity of the consequences of 223 
MEs lower than pharmacists [24-26]. The observed high level of agreement in the assessment of 224 
clinical significance of the MEs presented in this study might be due to less ambiguity in statements 225 
of the outcomes of the MEs in the case studies, as opposed to documented interventions without clear 226 
endpoints in the aforementioned studies. Furthermore, the majority of participants in this study 227 
thought the MEs were the consequence of action/inaction of at least two health professionals. It has 228 
been evident in this study that there was no clear pattern with each group to blame the other two 229 
groups. In this sense, the health professionals substantiate the accountability of roles and 230 
acknowledgment of shared responsibilities and teamwork in patient care. To some extent, the findings 231 
of this study confirmed those of previous studies highlighting the nature of the healthcare process as 232 
being ‘tightly coupled’ and ‘interdependent’, whereby deviations during the process were likely due 233 
to the results of interactions among the care providers rather than a single person [7, 14]. 234 
In the present study, the varied responses to the likely contributing factors to each ME suggests 235 
robustness in the simulated cases and depth of consideration by respondents. Furthermore, it 236 
highlights the complexity in identifying root causes for errors, a concept recognised in the literature 237 
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[14, 27, 28]. Two contributing factors that were consistently identified by the researchers and 238 
participants in all five cases were dismissal of policies/procedures or guidelines, and human 239 
resources. As with this study, RCA of 17 critical incidents in a children’s hospital in the Netherlands 240 
found task and team factors were the most frequent contributing factors [14]. The task factors were 241 
associated with awareness among the staff regarding the existence and implementation of clinical 242 
guidelines and/or hospital protocols. Team factors referred to issues that can be resolved through 243 
training [14]. 244 
The findings of a report on incident management (including medication-related incidents) in the New 245 
South Wales public health system during 2005-2006 was in accordance with those of this study [29]. 246 
That study found issues related to policy and procedures, and communication (particularly 247 
deficiencies in patient handover) to be the major contributing factors [29]. Consistent with this study, 248 
RCA reports on adverse drug events submitted to the Veteran Affairs National Center for Patient 249 
Safety in the USA in 2004 uncovered problems with policies or procedures, staff training and 250 
education, communication, and equipment as common factors contributing to adverse drug events 251 
[30]. Meanwhile, analysis of ME reports submitted to MedMARx (a National Medication Error 252 
Reporting Program in the USA) revealed workplace distractions, staffing issues and workload 253 
increases as the most frequently cited contributing factors related to MEs during hospitalization [31]. 254 
The similar perceptions among the health professionals collectively in our study indicated the key 255 
professions are capable of identifying contributing factors to medication safety-related events.  256 
As the contributing factors of MEs are numerous, evidence underlines the need for multiple strategies 257 
for ME prevention [32]. Accordingly, analysis of the common themes of strategies proposed by 258 
participants in this study identified the need for numerous strategies to prevent each ME. In line with 259 
this study, the aforementioned Dutch study reported an average of five recommendations per analysis; 260 
most recommendations related to task factors (36%), and required providing and/or adjusting hospital 261 
protocols or guidelines (43%) [14]. The other recommendations were associated with team-based staff 262 
training and technical adjustment to improve the work environment (e.g. quiet area for medication 263 
preparation unit) [14]. In addition, findings of the current study correspond with strategies for ME 264 
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prevention in peadiatrics recommended by the American Academy of Pediatrics Committee on Drugs 265 
and the Committee on Hospital Care [33] and the Pediatric Pharmacy Advocacy Group [34]. 266 
 267 
As suggested by this study and other RCA studies, education of healthcare staff is an important 268 
component of  ME reduction [32, 35]. Pharmacists, with their knowledge and expertise of medicines, 269 
are ideal educators for other health professionals, and their educator role has been shown to be an 270 
effective ME prevention measure in a range of patient populations [33, 36]. Patient empowerment is 271 
also recognised as a valuable strategy for ME prevention. Healthcare staff should educate patients 272 
(and in the present case, families of paediatric patients) [37, 38] to improve their health literacy 273 
regarding their medical conditions, medications and healthy lifestyles [39]. One common issue among 274 
healthcare staff is their lack of awareness of hospital policies and procedures. In the current study, it 275 
has been suggested that pharmacists are able to contribute not only to development of policies on 276 
medication use (e.g. high-risk drugs, discharge medications), but also to communicate these policies 277 
to other staff. Our study also confirmed the findings of previous RCA research that identified the 278 
necessity of adequate communication between staff and patients and their families [40-42]. 279 
There are several limitations to this study. The response rate was low, possibly due to the perceived 280 
time requirement to complete the task, and the study involved a single institution. A larger number of 281 
participants and involvement of other paediatric institutions may reveal different trends in the data on 282 
the clinical significance of the MEs, the contributing factors and participants’ suggestions for ME 283 
prevention. Additionally, presentation of pre-determined options could bias the results. The pre-284 
determined options were determined via consensus between the researchers, and other clinical experts 285 
may give different assessments.  286 
 287 
5. Conclusion 288 
This is the first-known study demonstrating the use of RCA with simulated case studies in the field of 289 
paediatric medication safety. RCA successfully evaluated healthcare professionals’ (physicians’, 290 
nurses’ and pharmacists’) ability to assess the clinical significance of MEs, identify potential 291 
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contributing factors in MEs, and suggest strategies to prevent MEs. Knowledge and skills in this area 292 
are critical in minimising medication misadventure in clinical practice and ensuring optimal patient 293 
outcomes. 294 
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Table 1. Researchers’ pre-determined factors contributing to the mediction errors 397 
Contributing factors  Case 1 Case 2 Case 3 Case 4 Case 5 
Patient specific issues Y N Y Y Y 
16 
 
Dismissal of policies/procedures or 
guidelines 
Y Y Y Y Y 
Human resources Y Y Y Y Y 
Miscommunication Y Y Y Y Y 
Physical environment of the health 
service 
N Y N N N 
Control/provision of medication Y Y Y N N 
‘Other’ N N N N N 
Y = contributing factor, N = non-contributing factor 398 
 399 
  400 
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Table 2. Description of participants 401 
Characteristics Number of participants (%) 
Physicians (n=6) Nurses (n=11) Pharmacists (n=8) 
Age (years) 
21-30  
31-40  
41-50  
>50  
 
1 (16.7) 
4 (66.7) 
0 (0.0) 
1 (16.7) 
 
3 (27.3) 
4 (36.4) 
2 (18.2) 
2 (18.2) 
 
0 (0.0) 
5 (62.5) 
1 (12.5) 
2 (25.0) 
Gender 
Male 
Female 
 
2 (33.3) 
4 (66.7) 
 
1 (9.1) 
10 (90.9) 
 
1 (12.5) 
7 (87.5) 
Clinical experience 
(years)  
<5  
5-10  
11-20  
>20  
 
 
0 (0.0) 
2 (33.3) 
3 (50.0) 
1 (16.7) 
 
 
2 (18.2) 
2 (18.2) 
4 (36.4) 
3 (27.3) 
 
 
0 (0.0) 
2 (25.0) 
3 (37.5) 
3 (37.5) 
Paediatric experience 
(years) 
<5  
5-10  
11-20  
>20  
 
 
0 (0.0) 
2 (33.3) 
3 (50.0) 
1 (16.7) 
 
 
2 (18.2) 
4 (36.4) 
4 (36.4) 
1 (9.1) 
 
 
2 (25.0) 
4 (50.0) 
2 (25.0) 
0 (0.0) 
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Table 3. Factors perceived to contribute to the medication error 404 
Factors Number of participants, N=25 (%) 
Case 1 Case 2 Case 3 Case 4 Case 5 
Patient specific issues 13 (52) 1 (4) 8 (32) 22 (88) 11 (44) 
Dismissal of policies/ 
procedures or guidelines 
1. Error/omission in 
medication 
reconciliation 
2. Clinical guidelines 
3. Coordination of care 
4. Medical record 
documentation 
5. Level and frequency of 
monitoring of patient 
24 (96) 
 
8 (32) 
 
 
15 (60) 
9 (36) 
15(60) 
 
7 (28) 
25 (100) 
 
14 (56) 
 
 
15 (60) 
11 (44) 
1 (4) 
 
0 (0) 
23 (92) 
 
15 (60) 
 
 
8 (32) 
19 (76) 
2 (8) 
 
4 (16) 
20 (80) 
 
4 (16) 
 
 
0 (0) 
12 (48) 
12 (48) 
 
2 (8) 
 
20 (80) 
 
15 (60) 
 
 
3 (12) 
3 (12) 
7 (28) 
 
1 (4) 
Human resources issues 
1. Staff workload and 
inadequate staffing 
2. Recruitment 
3. Staff training and 
competencies 
4. Staff supervision 
22 (88) 
10 (40) 
 
0 (0) 
20 (80) 
 
14 (56) 
24 (96) 
19 (76) 
 
0 (0) 
14 (56) 
 
14 (56) 
23 (92) 
15 (60) 
 
0 (0) 
15 (60) 
 
7 (28) 
16 (64) 
2 (8) 
 
1 (4) 
12 (48) 
 
1 (4) 
24 (96) 
24 (96) 
 
4 (16) 
9 (36) 
 
6 (24) 
Miscommunication 
1. Miscommunication 
between staff 
2. Miscommunication 
between staff and 
patient and/or family 
13 (52) 
13 (52) 
 
2 (8) 
8 (32) 
5 (20) 
 
5 (20) 
22 (88) 
22 (88) 
 
7 (28) 
24 (96) 
15 (60) 
 
20 (80) 
9 (36) 
8 (32) 
 
6 (24) 
Physical environment of 
the health service 
1(4) 23 (92) 0 (0) 0 (0) 
 
0 (0) 
Control/provision of 
medication 
1. Medication storage 
2. Labeling 
3. Documentation of 
administration 
4. Internal transfer of 
medication 
11 (44) 
 
1 (4) 
1 (4) 
5 (20) 
 
3(12) 
 
20 (80) 
 
14 (56) 
9 (36) 
1 (4) 
 
6 (24) 
21 (84) 
 
4 (16) 
1 (4) 
3 (12) 
 
17 (68) 
3 (12) 
 
0 (0) 
1 (4) 
1 (4) 
 
0 (0) 
9 (36) 
 
0 (0) 
0 (0) 
9 (36) 
 
0 (0) 
‘Other’  9 (36) 14 (56) 6 (24) 4 (16) 10 (40) 
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Table 4. Agreement betweenresearchers and participants regarding contributing 407 
factors 408 
Variables Odds ratio of contributing factors (p-value)* 
Patient-specific 
issues 
Human 
resources 
Communication Control/ 
provision of 
medication 
Case study# 
Case 1 (Prescribing error) 
Case 2 (Dispensing error) 
Case 3 (Administration error) 
Case 4(Communication and 
documentation error) 
Case 5 (Transcribing error)** 
 
0.702 (0.406) 
0.027 (0.003) 
1.748 (0.369) 
0.090 (0.001) 
 
1 
 
3.290 (0.160) 
1.000 (1.000) 
2.093 (0.568) 
13.744 (0.006) 
 
1 
 
0.501 (0.318) 
1.205 (0.763) 
0.067 (<0.001) 
0.020 (<0.001) 
 
1 
 
2.299 (0.191) 
0.439 (0.206) 
0.334 (0.132) 
0.238 (0.034) 
 
1 
Participants’ role## 
Physician 
Nurse 
Pharmacist** 
 
1.114 (0.865) 
3.719 (0.039) 
1 
 
1.677 (0.541) 
1.044 (0.954) 
1 
 
0.299 (0.030) 
0.402 (0.125) 
1 
 
0.522 (0.382) 
1.068 (0.900) 
1 
*Using General Estimating Equation analysis 409 
**Set as a reference 410 
#High agreement across the four contributing factors was seen in Case 4. 411 
##Nurses shared less agreement with pre-determined answers regarding the contribution of patient-specific 412 
issues. Physicians were more likely to agree with researchers signifying communication as the contributing 413 
factor. No agreement with pre-determined answers for human resources and control/provision of medication as 414 
contributing factors of MEs. 415 
 416 
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 418 
 419 
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